Expression of EVI1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13-14)

American Journal of Hematology

Volumn 53, Issue 1, 1996, Pages 30-34

  Yufu, Yuji ^a   Sadamura, S ^a   Ishikura, H ^a   Abe, Y ^b   Katsuno, M ^c   Nishimura, J ^a   Nawata, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Shakaihoken Nakabaru Hospital   (Japan)

^c Fukuoka Medical Association Hospital   (Japan)

Author keywords

chromosomal translocation; chromosome 13; chromosome 3; EVI1 gene; Rb gene

Indexed keywords

RETINOBLASTOMA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 3; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; RETINOBLASTOMA PROTEIN; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029796189     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199609)53:1<30::AID-AJH6>3.0.CO;2-6     Document Type: Article

References (26)

1. Morishita K, Parganas E, Bartholomew C, Sacchi N, Valentine MB, Raimondi SC, Le Beau MM, Ihle JN: The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations. Oncogene Res 5:221-231, 1990.
2. Morishita K, Parganas E, Douglass EC, Ihle JN: Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: Sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 5:963-971, 1990.
3. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN: Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54:831-840, 1988.
4. Kreider BL, Orkin SH, Ihle JN: Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc Natl Acad Sci USA 90:6454-6458, 1993.
5. Morishita K, Parganas E, Matsugi T, Ihle JN: Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 12:183-189, 1992.
6. Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea JM, Gisselbrecht S: Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia 6:93-99, 1992.
7. Russell M, Thompson F, Spier C, Taetle R: Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis. Leukemia 7:1654-1657, 1993.
8. Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB, Ihle JN: Activation of EV11 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89:3937-3941, 1992.
9. Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN, Buckle VJ: DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 83:1348-1354, 1994.
10. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN: Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 91:4004-4008, 1994.
11. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H: Generation of the AML1-EVI-1 fusion gene in the t(3;21 )(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504-510, 1994.
12. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431-10434, 1991.
13. Lee W-H, Bookstein R, Hong F, Young L-J, Shew J-Y, Lee EY-H: Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 235:1394-1399, 1987.
14. Tang J-L, Yeh S-H, Chen P-J, Lin M-T, Tien H-F, Chen Y-C: Inactiva- lion of the retinoblastoma gene in acute myelogenous leukaemia. Br J Haematol 82:502-507, 1992.
15. Komblau SM, Xu H-J, Zhang W, Hu S-X, Beran M, Smith TL, Hester J, Estey E, Benedict WF, Deisseroth AB: Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 84:256-261, 1994.
16. Katsuno M, Yamashita S, Sadamura S, Umemura T, Hirata J, Nishimura J, Nawata H: Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: Detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage. Br J Haematol 87:51-56, 1994.
17. Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J, Katsuno M, Masuda S, Sasaki R, Fukumaki Y, Nawata H, Okano H: A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia. Leukemia 4:365-372, 1990.
18. Kumar R, Atlas I: Interferon a induces the expression of the retinoblastoma gene product in human Burkitt lymphoma Daudi cells: Role in growth regulation. Proc Nail Acad Sci USA 89:6599-6603, 1992.
19. Sadamura S, Umemura T, Takahira H, Hirata J, Nishimura J, Nawata H: Analysis of clonality at the level of progenitors in chronic myelogenous leukaemia using the polymerase chain reaction. Leuk Res 16:371-377, 1992.
20. Maniatis T, Fritsch EF, Sambrook JJ: "Molecular Cloning: A Laboratory Manual." New York: Cold Spring Harbor Laboratory, 1982, pp. 187-210.
21. Wiggs J, Nordenskjold M, Yandell D, Rapaport J, Grondin V, Janson M, Werelius B, Petersen R, Craft A, Riedel K, Liberfarb R, Walton D, Wilson W, Dryja TP: Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med 318:151-157, 1988.
22. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R: Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84:1243-1248, 1994.
23. Chen Y-C, Chen P-J, Yeh S-H, Tien H-F, Wang C-H, Tang J-L, Hong R-L: Deletion of the human retinoblastoma gene in primary leukemias. Blood 76:2060-2064, 1990.
24. Liu Y, Szekely L, Grander D, Soderhall S, Juliusson G, Gahrton G, Linder S, Einhorn S: Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RDI gene: Evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 90:8697-8701, 1993.
25. Hirai H, Kobayashi Y, Mano H, Hagiwara K, Maru Y, Omine M, Mizoguchi H, Nishida J, Takaku F: A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 327:430-432, 1987.
26. Ahuja H, Bar-Eli M, Arlin Z, Advani S, Allen SL, Goldman J, Snyder D, Foti A, Cline M: The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J Clin Invest 87:2042-2047, 1991.